NCT00765089

Brief Summary

Atrial Fibrillation (AF) is one of the most common postoperative complications after coronary artery bypass grafting (CABG). Postoperative AF produces a substantial impact on hospital resources with an estimated annual expenditure of over $1 billion. This includes the cost of pharmacological treatment and the cost of the increased length of stay. The incidence of AF is about 30-40% in CABG patients and increases with age of the patient. As the average age of the patient that undergoes CABG surgery is increasing, it is critical to find a way to prevent or reduce the incidence of this complication. We propose a prospective, randomized, controlled study to determine the role of pulmonary vein isolation by bipolar ablation in the prevention or reduction of postoperative AF. The block- randomization plan will be used to maintain balance of the study and control arms throughout the study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Dec 2005

Longer than P75 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2005

Completed
2.8 years until next milestone

First Submitted

Initial submission to the registry

September 30, 2008

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 2, 2008

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2010

Completed
Last Updated

February 12, 2016

Status Verified

February 1, 2016

Enrollment Period

4.2 years

First QC Date

September 30, 2008

Last Update Submit

February 11, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Reduced incidence of Postoperative Atrial fibrillation

    12 hours

Study Arms (2)

Pulmonary Vein isolation

EXPERIMENTAL

Patients in this arm will receive pulmonary vein isolation during surgery

Procedure: Isolation of pulmonary veins with Bipolar radiofrequency ablation

Standard of care

NO INTERVENTION

Subjects in this arm will receive standard of care and no pulmonary vein isolation

Interventions

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who require an isolated elective CABG surgery on CPB.
  • Both male and female patients of age 18 years to 90 years.

You may not qualify if:

  • Pre existing atrial fibrillation or history of previous atrial fibrillation.
  • Inability to provide informed consent.
  • Pregnant or nursing patients.
  • Reoperative sternotomy
  • Emergency CABG surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, 15102, United States

Location

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

September 30, 2008

First Posted

October 2, 2008

Study Start

December 1, 2005

Primary Completion

March 1, 2010

Study Completion

March 1, 2010

Last Updated

February 12, 2016

Record last verified: 2016-02

Locations